Use of prokineticin-1 (PROK1), pregnancy-associated plasma protein A (PAPP-A) and PROK1/PAPP-A ratio to predict adverse pregnancy outcomes in the first trimester: a prospective study. (18th October 2018)
- Record Type:
- Journal Article
- Title:
- Use of prokineticin-1 (PROK1), pregnancy-associated plasma protein A (PAPP-A) and PROK1/PAPP-A ratio to predict adverse pregnancy outcomes in the first trimester: a prospective study. (18th October 2018)
- Main Title:
- Use of prokineticin-1 (PROK1), pregnancy-associated plasma protein A (PAPP-A) and PROK1/PAPP-A ratio to predict adverse pregnancy outcomes in the first trimester: a prospective study
- Authors:
- Inan, Cihan
Varol, Fusun Gulizar
Erzincan, Selen Gursoy
Uzun, Isil
Sutcu, Havva
Sayin, N. Cenk - Abstract:
- Abstract: Introduction: To compare the predictive effectiveness levels of prokineticin-1 (PROK1), pregnancy-associated plasma protein A (PAPP-A) and the PROK1/PAPP-A ratio in the first trimester for preeclampsia (PE), foetal growth restriction (FGR), gestational diabetes mellitus (GDM) and spontaneous preterm birth (SPB). Materials and methods: A total of randomly selected 162 pregnant women were included. Peripheral blood samples were obtained between 11 0/7 and 13 6/7 gestational weeks (GWs). All women were followed throughout the pregnancy and classified into five groups as having PE, FGR, GDM, SPB and uncomplicated pregnancies. The cut-off levels of the markers were identified to predict adverse outcomes. Results: PROK1 predicted PE with 83.3% sensitivity, 85.7% specificity at a value of >293.4 pg/mL; at a value of >260.2 pg/mL, PROK1 predicted FGR with 85.7% sensitivity, 72.5% specificity in the first trimester. The area under receiver operating characteristic (ROC) curve of PAPP-A was lower than that of PROK1 and PROK1/PAPP-A in differentiating PE and FGR from the uncomplicated group ( p < .001). PROK1 levels and the PROK1/PAPP-A ratios in the SPB and GDM groups were lower than in the uncomplicated group ( p < .01). Conclusions: Elevated PROK1 in the first trimester is a more effective marker than PAPP-A in the prediction of PE and FGR. Lower PROK1 levels are associated with the development of SPB and GDM.
- Is Part Of:
- Journal of maternal-fetal & neonatal medicine. Volume 31:Number 20(2018)
- Journal:
- Journal of maternal-fetal & neonatal medicine
- Issue:
- Volume 31:Number 20(2018)
- Issue Display:
- Volume 31, Issue 20 (2018)
- Year:
- 2018
- Volume:
- 31
- Issue:
- 20
- Issue Sort Value:
- 2018-0031-0020-0000
- Page Start:
- 2685
- Page End:
- 2692
- Publication Date:
- 2018-10-18
- Subjects:
- Foetal growth retardation; gestational diabetes mellitus -- preeclampsia -- preterm birth -- prokinecin 1
Obstetrics -- Periodicals
Perinatology -- Periodicals
Infants (Newborn) -- Diseases -- Periodicals
Neonatology -- Periodicals
618.2 - Journal URLs:
- http://informahealthcare.com/loi/jmf ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14767058.2017.1351536 ↗
- Languages:
- English
- ISSNs:
- 1476-7058
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5012.332000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 6838.xml